Literature DB >> 7612242

Production and purification of recombinant African swine fever virus attachment protein p12.

A L Carrascosa1, I Sastre, E Viñuela.   

Abstract

The conditions for cultivation of Spodoptera frugiperda (Sf9) insect cells for production of recombinant baculoviruses have been studied, to scale-up and improve the efficiency of the process for production of the African swine fever virus attachment protein p12 in the baculovirus expression system. It was shown that the total virus and recombinant protein production in insect cells infected with the Acp12 recombinant baculovirus were slightly dependent on cell density, but largely dependent on the serum concentration, in the case of suspended cells, but not in static monolayer cultures. The yield of recombinant protein p12 exceeded 50 mg per 1 of 2 x 10(9) cells, representing more than 10% of total cell proteins, a level > 20-fold higher than that observed with other eukaryotic expression systems. The presence of p12 in the cytoplasmic fraction of infected cells has allowed the purification of the protein by a simple two-step procedure of aqueous phase partition and octyl-glucoside solubilization. The recombinant protein p12 was able to inhibit, in a dose-dependent manner, the African swine fever virus production in swine macrophages infected with a number of different virus isolates, including attenuated, virulent, highly passaged on tissue culture, and non-haemadsorbing strains, indicating a fundamental role for p12 in the early interaction of the virus with the natural target cell receptors. However, pigs immunized with purified recombinant p12 did not develop protective immunity against African swine fever.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612242     DOI: 10.1016/0168-1656(95)00035-o

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  6 in total

1.  Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization.

Authors:  P Gómez-Puertas; F Rodríguez; J M Oviedo; F Ramiro-Ibáñez; F Ruiz-Gonzalvo; C Alonso; J M Escribano
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Roles of African Swine Fever Virus Structural Proteins in Viral Infection.

Authors:  Ning Jia; Yunwen Ou; Zygmunt Pejsak; Yongguang Zhang; Jie Zhang
Journal:  J Vet Res       Date:  2017-12-06       Impact factor: 1.744

Review 3.  Spatiotemporally Orchestrated Interactions between Viral and Cellular Proteins Involved in the Entry of African Swine Fever Virus.

Authors:  Kehui Zhang; Su Li; Sheng Liu; Shuhong Li; Liang Qu; George F Gao; Hua-Ji Qiu
Journal:  Viruses       Date:  2021-12-13       Impact factor: 5.048

Review 4.  Viral Vector Vaccines Against ASF: Problems and Prospectives.

Authors:  Rustam Kh Ravilov; Albert A Rizvanov; Danil N Mingaleev; Antonina G Galeeva; Elena Yu Zakirova; Eduard A Shuralev; Catrin S Rutland; Nail I Khammadov; Marina A Efimova
Journal:  Front Vet Sci       Date:  2022-03-11

Review 5.  African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives.

Authors:  James J Zhu
Journal:  Viruses       Date:  2022-09-13       Impact factor: 5.818

Review 6.  African swine fever: Etiology, epidemiological status in Korea, and perspective on control.

Authors:  Dongwan Yoo; Hyunil Kim; Joo Young Lee; Han Sang Yoo
Journal:  J Vet Sci       Date:  2020-03       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.